Epidemiology and antibiotic resistance in a large Italian teaching hospital

References

• Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill [Internet]. 2008 Nov 20 [cited 2013 Apr 3]; 13(47):pii = 19045. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId = 19045
   Google Scholar
• Bellissima P, Amato R, Bonfante S. Antibiotic resistance monitoring of nosocomial clinical isolates. Infez Med. 2000;8:211–5.
   PubMedGoogle Scholar
• Camporese A, Santini G. Surveillance of antibiotic-resistant microorganisms for the rational use of antimicrobial drugs. Infez Med. 1999;7:172–6.
   PubMedGoogle Scholar
• Gattuso G, Tomasoni D, Palvarini L, Chiarelli C, Nespeca M, Stradoni R, et al. Epidemiology of ESBL-positive Enterobacteriaceae in Mantova hospital (Italy). Infez Med. 2009;17:164–8.
   PubMedGoogle Scholar
• Menichetti F, Tascini C, Ferranti S, Moroni A, Balbone L, Bozza S, et al. Clinical and molecular epidemiology of an outbreak of infusion-related Acinetobacter baumannii bacteremia in an Intensive Care Unit. Infez Med. 2000;8:24–9.
   Google Scholar
• Cuniato V, Bellitti F, D’Isanto R, De Sio A, Marvaso A, Esposito S. Microbiological survey in an Intensive Care Unit. Infez Med. 1999;7:245–52.
   PubMedGoogle Scholar
• Franchi C, Venditti M, Rocco M, Spadetta G, Vullo V, Raponi M, et al. Microbiological surveillance in an intensive care unit of a large roman hospital. Infez Med. 2002;10:93–9.
   PubMedGoogle Scholar
• Peleg AY, Hooper DC. Hospital-acquired infections due to Gram-negative bacteria. N Engl J Med. 2010;362:1804–13.
   PubMed Web of Science ®Google Scholar
• Giamarellou H, Poulakou G. Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs. 2009;69:1879–901.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) [document on Internet]. Stockholm: ECDC; 2012 [cited 2013 Apr 3]; doi 10·2900/6551. Available from: http://www.ecdc.europa.eu
   Google Scholar
• Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29:996–1011. [Erratum, Infect Control Hosp Epidemiol. 2009;30:107].
   PubMed Web of Science ®Google Scholar
• Gaynes R, Edwards JR. Overview of nosocomial infections caused by Gram-negative bacilli. Clin Infect Dis. 2005;41:848–54.
   PubMed Web of Science ®Google Scholar
• Maltezou HC, Kontopidou F, Katerelos P, Daikos G, Roilides E, Theodoridou M. Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children. Pediatr Infect Dis J. 2013;32:e151–4.
   PubMed Web of Science ®Google Scholar
• Marwick C, Santiago VH, McCowan C, Broomhall J, Davey P. Community acquired infections in older patients admitted to hospital from care homes versus the community: cohort study of microbiology and outcomes. BMC Geriatr [Internet]. 2013 Feb 6 [cited 2013 Apr 3];13:12. Available from: http://www.biomedcentral.com/1471-2318/13/12
   Google Scholar
• Liu XT, Wang GL, Luo XF, Chen YL, Ou JB, Huang J, et al. Spectrum of pathogens for community-acquired pneumonia in children. Zhongguo Dang Dai Er Ke Za Zhi. 2013;15:42–5.
   PubMedGoogle Scholar
• Baroud M, Dandache I, Araj GF, Wakim R, Kanj S, Kanafani Z, et al. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases. Int J Antimicrob Agents. 2013;41:75–9.
   PubMed Web of Science ®Google Scholar
• De Vecchi E, Drago L, Nicola L, Colombo A, Guerra A, Tocalli L, et al. Resistance of Pseudomonas aeruginosa to ciprofloxacin and levofloxacin: 1998-2002. Infez Med. 2003;11:196–200.
   PubMedGoogle Scholar
• Tomasoni D, Gattuso G, Chiarelli C, Palvarini L, Ceruti R, Berra D, et al. Epidemiologic surveillance of multi-drug resistant Pseudomonas aeruginosa in Mantova Hospital (Italy). Infez Med. 2006;14:85–91.
   PubMedGoogle Scholar
• Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Disease Society of America. Clin Infect Dis. 2008;46:155–64.
   PubMed Web of Science ®Google Scholar
• Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKCAPE. J Infect Dis. 2008;197:1079–81.
   PubMed Web of Science ®Google Scholar
• Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1–12.
   PubMed Web of Science ®Google Scholar
• Gales AC, Jones RN, Sader HS. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09). J Antimicrob Chemother. 2011;66:2070–4.
   PubMed Web of Science ®Google Scholar
• Fernández-Cuenca F, Tomás-Carmona M, Caballero-Moyano F, Bou G, Martínez-Martínez L, Vila J, et al. In vitro activity of 18 antimicrobial agents against clinical isolates of Acinetobacter spp.: multicenter national study GEIH-REIPI-Ab 2010. Enferm Infecc Microbiol Clin. 2013;31:4–9.
   PubMed Web of Science ®Google Scholar
• Manfredi R, Nanetti A. An active microbiological surveillance project at an Italian teaching hospital: microbial isolates, recent epidemiological trends, major clinical concerns, and antimicrobial susceptibility rates during a four-year period. Infez Med. 2009;17:219–27.
   PubMedGoogle Scholar